Can Cannabis Help with Epilepsy? Evidence, CBD Research & Legal Access in Canada

Note: Cannabis is for adults 19+ in Ontario. This content is for informational purposes only and is not medical advice. Consult a healthcare professional for cannabis-related health questions, especially regarding epilepsy or any seizure disorder.

Epilepsy is one of the most-studied conditions in cannabis research, and it's also one of the most misunderstood at the retail counter. Customers walk into our four Ontario stores asking some version of the same question every week: "Can cannabis help with epilepsy?" The honest answer involves clinical research on CBD, a Health Canada-approved drug called Epidiolex, and a clear line between what recreational retailers like us can discuss and what only a physician can prescribe. This guide breaks down the evidence, the legal pathways in Canada, and where adult-use CBD fits in. For background on how legal retail works in Ontario, see our overview of cannabis news and education on the Ashario blog.

Can cannabis help with epilepsy? What the research actually shows

Clinical research supports that purified cannabidiol (CBD), not whole-plant cannabis: reduces seizure frequency in two rare childhood epilepsy syndromes: Dravet syndrome and Lennox-Gastaut syndrome. A third indication, tuberous sclerosis complex (TSC), was added based on later trials. This evidence led to Health Canada's 2018 authorization of Epidiolex, a prescription CBD drug. Whole-flower cannabis from a retailer like Ashario is not a treatment for epilepsy.

The pivotal data come from three randomized controlled trials published between 2017 and 2018, where patients receiving 10 to 20 mg/kg/day of purified CBD saw roughly a 40 to 50% reduction in convulsive seizures versus around 20% on placebo. According to Health Canada, CBD products outside this prescription pathway are not approved for treating any medical condition, including seizure disorders.

That distinction matters at retail. Our budtenders can describe terpene profiles, CBD percentages, and product formats, but we cannot and will not recommend cannabis as epilepsy therapy. If you're exploring the science, browse our cannabis product categories for general CBD education, and speak to a neurologist about clinical options.

What is Epidiolex Canada, and how is it different from store-bought CBD?

Epidiolex is a Health Canada-approved prescription pharmaceutical containing 100 mg/mL of purified plant-derived CBD in a sesame oil solution, indicated for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients 2 years and older. It is dispensed by pharmacies, not cannabis retailers, and requires a prescription from a physician.

Store-bought CBD from a licensed Ontario cannabis retailer is fundamentally different in four ways:

• Regulatory class: Epidiolex is a Schedule prescription drug; retail CBD is a recreational cannabis product regulated under the Cannabis Act.
• Purity: Epidiolex is >98% pure CBD isolate; retail oils and capsules typically include carrier oils, sometimes trace THC (under 30 mg/unit limits), and occasional terpenes.
• Dosing: Epidiolex doses for epilepsy reach 10 to 20 mg/kg/day | far higher than recreational CBD products are formatted for.
• Coverage: Epidiolex may be covered by private insurance or provincial drug plans; retail CBD never is.

Customers sometimes ask whether they can substitute a 30 mL CBD oil bottle from our retail menu for Epidiolex. The short answer is no: the milligram math alone (an adult on 20 mg/kg/day would burn through a typical 1000 mg retail bottle in days) makes recreational products impractical and clinically uncontrolled.

CBD epilepsy Canada: what's the legal pathway for medical access?

In Canada, patients seeking cannabis for epilepsy have two legal pathways: a prescription for Epidiolex from a physician (dispensed through pharmacies), or medical cannabis authorization from a healthcare practitioner allowing purchase from a federally licensed producer. Recreational stores like Ashario operate under a separate Cannabis Act stream regulated provincially by the AGCO.

The medical cannabis route works like this: a nurse practitioner or physician issues a medical document specifying daily grams. Patients register directly with a Licensed Producer (LP) and order CBD oils, capsules, or dried flower shipped to their home. As of 2026, this pathway is separate from the retail system. You cannot use a medical document at a brick-and-mortar dispensary in Ontario.

For an overview of the legal Canadian cannabis system and where retail fits in, our team maintains a store locations and access guide. If you have questions about whether a specific product is suitable for a non-medical wellness routine (separate from any seizure-related use), contact Ashario Cannabis and one of our budtenders will walk you through retail CBD formats.

Cannabis seizure research: what's still unknown in 2026

While CBD is well-established for three rare epilepsy syndromes, cannabis seizure research is still evolving for the broader 1 in 100 Canadians living with epilepsy. Key open questions include whether THC helps or worsens seizures, whether full-spectrum products outperform isolates ("the entourage effect"), and whether CBD is effective for adult-onset focal epilepsy: the most common form.

Several findings are notable for 2026:

• THC and seizure threshold: Animal and limited human data suggest high-THC products may lower seizure threshold in some patients. Patients with epilepsy are generally advised to avoid high-THC flower and concentrates.
• Drug interactions: CBD inhibits the CYP450 enzyme system and can raise blood levels of clobazam, valproate, and warfarin, a clinically significant interaction.
• Pediatric monitoring: Liver enzyme elevations occur in roughly 15% of Epidiolex patients, requiring blood tests every 1, 3, and 6 months after starting.
• Tolerance: Some long-term studies show CBD efficacy waning after 12 to 24 months in a subset of patients.

The Statistics Canada Cannabis Stats Hub tracks medical authorization volumes; as of recent reporting, roughly 250,000 Canadians hold active medical cannabis registrations, with epilepsy among the listed indications.

Where does retail CBD fit in? Honest guidance from Ashario budtenders

Retail CBD products at Ashario Cannabis are recreational wellness items: oils, capsules, beverages, and low-dose edibles regulated under Ontario's adult-use framework. They are not substitutes for prescribed epilepsy medication. Our budtenders are trained to explain formats, milligram counts, and onset times, but we redirect any seizure-related questions to a physician.

That said, plenty of customers come to our four stores looking for general-wellness CBD, for sleep, post-workout routines, or simply curiosity. Common retail CBD formats include 30 mL oils with 1:0 or 1:1 CBD:THC ratios, 10 mg single-serving capsules, and 2.5 to 10 mg CBD beverages.

Visit any of our four Ontario locations seven days a week, 7 AM to 11 PM:

• Finch & Dufferin: 1111A Finch Ave W Unit 1, North York | 647-368-7722
• Centerpoint Mall: 6464 Yonge St Unit #187, North York | 416-477-9333
• Aurora: 15114 Yonge St, Aurora | 905-503-6770
• Thornton: 239 Barrie St, Thornton | 249-733-9333

For full store details, see our Ontario store locations page or browse cannabis product categories online before visiting.

Talking to your doctor: questions worth asking

If you or a family member has epilepsy and you're considering any cannabis-based option, the conversation belongs in your neurologist's office, not at a retail counter. Useful questions to bring to that appointment include whether Epidiolex is appropriate for your seizure type, what the dosing schedule and monitoring plan looks like, and whether any current medications create CYP450 interactions.

You can also ask about the medical cannabis authorization pathway through a Licensed Producer if Epidiolex isn't suitable. Resources for caregivers and youth-specific safety guidance are available from Drug Free Kids Canada, particularly relevant for pediatric epilepsy cases where caregivers handle dosing.

Frequently Asked Questions

Can I buy CBD for epilepsy at an Ashario Cannabis store?

You can purchase recreational CBD products at any of our four Ontario locations if you're 19+, but these products are not approved or appropriate as epilepsy treatment. Health Canada-approved CBD therapy for epilepsy is delivered via prescription Epidiolex through pharmacies, or via the medical cannabis stream through a Licensed Producer with a physician's authorization. Our budtenders will redirect any seizure-related medical questions to a healthcare professional. Recreational CBD at retail is a wellness category, regulated separately from medical cannabis.

Is Epidiolex available in Canada and is it covered by insurance?

Yes. Epidiolex received Health Canada approval in 2018 for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients 2 years and older. It's a prescription-only pharmaceutical containing 100 mg/mL of purified CBD, dispensed through pharmacies. Coverage varies: many private insurance plans cover it with prior authorization, and provincial drug programs may offer coverage on a case-by-case basis. Speak with your neurologist and pharmacist about access, dosing (typically 10 to 20 mg/kg/day), and the required liver enzyme monitoring at 1, 3, and 6 months.

Does THC help or worsen seizures?

Current research suggests THC's relationship with seizures is more complicated than CBD's. Some animal studies and limited human reports indicate high-THC products may lower seizure threshold in susceptible individuals, while CBD has well-documented anticonvulsant effects. For this reason, patients with epilepsy are generally advised by neurologists to avoid high-THC flower, vapes, and concentrates. If you have epilepsy and are considering any cannabis product, even a low-dose recreational one from our shelves, discuss it with your physician first.

What's the difference between medical cannabis and recreational cannabis in Canada?

Medical cannabis requires a medical document from a nurse practitioner or physician, registration directly with a federally Licensed Producer, and home delivery. It cannot be purchased at retail stores. Recreational cannabis (what Ashario sells) is regulated provincially, requires only proof of age 19+, and is sold in-store or for click-and-collect pickup. As of 2026, the two streams are entirely separate in Ontario. Some patients use both: medical for therapeutic indications, recreational for wellness or social use.

Can children use CBD for epilepsy in Canada?

Pediatric epilepsy patients can access CBD therapy only through prescription Epidiolex (approved for ages 2+) or through medical cannabis authorization from a pediatric neurologist working with a Licensed Producer. Recreational cannabis retailers like Ashario serve adults 19+ only. We cannot sell to anyone under the legal age and our products are not intended for pediatric use under any circumstances. Caregivers managing pediatric epilepsy dosing should work exclusively with the prescribing physician and pharmacist.

Are there drug interactions I should know about with CBD?

Yes. CBD inhibits the cytochrome P450 enzyme system, particularly CYP3A4 and CYP2C19, which can raise blood levels of several medications. The most clinically significant interactions for epilepsy patients involve clobazam (Frisium), valproate (Depakote), and warfarin. Even retail CBD products in higher doses may interact with these and other medications. Always disclose all cannabis use, recreational or medical, to your prescribing physician and pharmacist. For general guidance on cannabis safety, see Health Canada's cannabis resources.